Use of Artificial Intelligence (AI) to Predict Clinical Outcomes in Patients Hospitalized for COVID19 Pneumonia During the 4 Pandemic Waves
Launched by AZIENDA OSPEDALIERA DI LECCO · May 21, 2024
Trial Information
Current as of March 12, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> 18 years;
- • Hospitalization for COVID-19 pneumonia at ASST Lecco.
- Exclusion Criteria:
- • Hospitalization or finding of asymptomatic SARS CoV-2 infection.
About Azienda Ospedaliera Di Lecco
Azienda Ospedaliera di Lecco is a prominent healthcare organization in Italy, dedicated to providing high-quality medical services and advancing clinical research. Committed to improving patient outcomes, the institution integrates clinical practice with innovative research initiatives across various medical disciplines. With a focus on collaboration and excellence, Azienda Ospedaliera di Lecco actively participates in clinical trials aimed at developing new therapies and enhancing healthcare practices, ensuring adherence to rigorous ethical standards and regulatory requirements. Through its comprehensive approach, the organization strives to contribute significantly to the advancement of medical knowledge and the improvement of patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lecco, , Italy
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
